Category

NASDAQ

Sohu.com Reports First Quarter 2021 Unaudited Financial Results NASDAQ

Sohu.com Reports First Quarter 2021 Unaudited Financial Results

BEIJING, May 14, 2021 /PRNewswire/ -- Sohu.com Limited (NASDAQ: SOHU), China's leading online media, video, gaming and search business group, today reported unaudited financial results for the first quarter ended March 31, 2021. In view of the previously-announced Share Purchase Agreement between subsidiaries of Tencent Holdings Limited ("Tencent") and the Company…
bubmag
May 14, 2021
FSD Management and Board Suffers Multiple Court Losses as Shareholder Meeting Approaches NASDAQ

FSD Management and Board Suffers Multiple Court Losses as Shareholder Meeting Approaches

TORONTO, May 13, 2021 - (ACN Newswire) - On Monday, May 10, 2021, at the request of Messrs. Anthony Durkacz and Zeeshan Saeed, founding shareholders and members of the group of concerned shareholders (the "Concerned Shareholders") of FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A) (the "Company" or "FSD"),…
bubmag
May 13, 2021
Stock futures are flat after Dow’s worst day since February, key inflation data on deck NASDAQ

Stock futures are flat after Dow’s worst day since February, key inflation data on deck

U.S. stocks declined sharply on Wednesday as hotter-than-expected inflation data triggered massive selling, especially in technology shares. The Dow Jones Industrial Average fell 681.50 points, or 2%, to 33,587.66, posting its worst day since January. The blue-chip benchmark tumbled as much as 713 points at its session low. The S&P…
bubmag
May 12, 2021
Array Technologies Signs Supply Agreement With Nucor Corporation NASDAQ

Array Technologies Signs Supply Agreement With Nucor Corporation

ALBUQUERQUE, N.M., May 11, 2021 (GLOBE NEWSWIRE) -- Array Technologies (NASDAQ: ARRY) ("Array"), one of the world's largest manufacturers of ground-mounted systems used in solar energy projects, today announced that Nucor Corporation ("Nucor") has entered into an agreement with the company to produce certain components of its solar tracking system,…
bubmag
May 11, 2021
Incyte And MorphoSys Announce First Patient Dosed In Phase 3 FrontMIND Study Evaluating Tafasitamab Combination As A First-Line Treatment For Diffuse Large B-Cell Lymphoma NASDAQ

Incyte And MorphoSys Announce First Patient Dosed In Phase 3 FrontMIND Study Evaluating Tafasitamab Combination As A First-Line Treatment For Diffuse Large B-Cell Lymphoma

Incyte (INCY) - Get Report and MorphoSys AG (FSE:MOR; NASDAQ:MOR) today announced that the first patient has been dosed in the pivotal Phase 3 frontMIND study evaluating tafasitamab and lenalidomide in addition to rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) compared to R-CHOP alone as first-line treatment for high-intermediate and…
bubmag
May 11, 2021